MENU

Syphilis Diagnosis: Treponemal Algorithms from the Public Health Perspective

Sponsored by: DiaSorin
Speaker
  • Director, Public Health Laboratory, State of Tennessee Department of Health
    Biography
      Dr. Richard Steece is certified as the Public Health Laboratory Director at the State of Tennessee Department of Health. He came into this role with over 30 years of experience and is one of the nation's leading public health laboratory experts. Among his multiple admirable roles driving public health initiatives, Dr. Steece has recently served as the National Chlamydia Laboratory Coordinator for the Centers for Disease Control and Prevention (CDC) and as Science Advisor to the Association of Public Health Laboratories (APHL). Most recently, Dr. Steece is the incoming chair of the 2015 STD subcommittee for APHL, and he is continuing this appointment into 2016. Prior to his public health career working with every city, county and state public health laboratory in the US, Dr. Steece earned his PhD in Biology/Microbiology.

    Abstract

    Serology testing continues to be an indispensable tool for the management of several disease states, especially treponemal screening to monitor syphilis infection in the US. Come to this educational seminar to learn about key objectives in treponemal screening:


    • Discuss CDC Guidelines on treponemal screening: the necessity to perform two independent laboratory syphilis tests to confirm diagnosis

    • Describe diagnostic methods for diagnosing syphilis infection: the order in which they are performed impacts interpretation of results

    • Describe the potential benefits of screening with a treponema-specific IgG/IgM assay, followed by a non-treponemal test for confirmation: the “Reverse Sequence” algorithm 

    •  

     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources
    Attendees
    • See more